These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6438991)

  • 81. Testicular lymphomas: a clinicopathologic study of 35 cases.
    Turner RR; Colby TV; MacKintosh FR
    Cancer; 1981 Nov; 48(9):2095-102. PubMed ID: 7296517
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Are there any significant variations in the clinical or histological presentation of lymphoid pathologies over the course of time in Spain?
    Provencio M; Sabín P; Gómez Codina J; Rueda A; Llanos M; Gumá J; Quero Blanco C; Blasco A; Delgado JR; Cruz MÁ; Aguiar D; García-Arroyo FR; Herrero J; Lavernia J; Martínez Banaclocha N; Morales M; Fuster J; Sáez Cusi Á; Lobo F; Rodríguez Abreu D; de la Cruz L; Antón E; Rodríguez Jiménez A; Arízcun A; Pérez X;
    Clin Transl Oncol; 2012 May; 14(5):386-90. PubMed ID: 22551546
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Incidence of thrombocytosis in lymphomas.
    Randi ML; Rossi C; Barbone E; Pietrogrande F; Girolami A
    Leuk Lymphoma; 1992 May; 7(1-2):139-41. PubMed ID: 1472925
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Clinical significance of circulating CD44 in non-Hodgkin's lymphoma.
    Ristamäki R; Joensuu H; Hagberg H; Kalkner KM; Jalkanen S
    Int J Cancer; 1998 Jun; 79(3):221-5. PubMed ID: 9645341
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Significance of haematological parameters in the non-Hodgkin's malignant lymphomas.
    Bloomfield CD; McKenna RW; Brunning RD
    Br J Haematol; 1976 Jan; 32(1):41-6. PubMed ID: 1259924
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Multiple histologic subtypes of non-Hodgkin's lymphoma: clinical and pathologic features.
    Leyser S; Variakojis D; Mintz U; Vardiman JW; Ultmann JE
    Cancer; 1981 Nov; 48(9):2063-9. PubMed ID: 7296513
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma.
    Gronowitz JS; Hagberg H; Källander CF; Simonsson B
    Br J Cancer; 1983 Apr; 47(4):487-95. PubMed ID: 6849793
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Intracellular lactic dehydrogenase and phosphohexose isomerase activity in leukaemia and malignant lymphoma.
    Ho AD; Fiehn W; Hunstein W
    Br J Haematol; 1982 Apr; 50(4):637-45. PubMed ID: 7066211
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Clinico-pathologic correlation in non-Hodgkin's lymphoma. I. Retrospective analysis using the Lukes and Collins classification.
    Lenner P; Lundgren E; Damber L
    Acta Radiol Oncol Radiat Phys Biol; 1979; 18(3):177-91. PubMed ID: 525424
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Unusual morphological features of adult T-cell leukemia cells with aberrant immunophenotype.
    Kamihira S; Sohda H; Atogami S; Fukushima T; Toriya K; Miyazaki Y; Ikeda S; Yamada Y; Tomonaga M
    Leuk Lymphoma; 1993 Dec; 12(1-2):123-30. PubMed ID: 8161929
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Prognostic factors in non-Hodgkin's lymphomas.
    Gobbi PG; Ricevuti G; Balduini C; Cavalli C; Gendarini A; Bonfichi M; Rizzo SC; Ascari E
    Acta Haematol; 1985; 74(2):86-91. PubMed ID: 3937421
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Clinico-pathologic correlation in non-Hodgkin's lymphoma. II. Clinical and prognostic significance of nodularity.
    Lenner P; Lundgren E; Damber L
    Acta Radiol Oncol Radiat Phys Biol; 1979; 18(5):417-30. PubMed ID: 532693
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Prognostic relevance of serum-markers in relation to histopathology, stage and initial symptoms in advanced low-grade non-Hodgkin lymphomas.
    Martinsson U; Glimelius B; Hagberg H; Sundström C
    Eur J Haematol; 1988 Apr; 40(4):289-98. PubMed ID: 3366218
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Lactate dehydrogenase in dermatology practice.
    Livesey A; Garty F; Shipman AR; Shipman KE
    Clin Exp Dermatol; 2020 Jul; 45(5):539-543. PubMed ID: 31755143
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Genetic Polymorphisms in NLRP3 Inflammasome-Associated Genes in Patients with B-Cell Non-Hodgkin's Lymphoma.
    Liu ZH; Zhang L; Jing FJ; Xiao SX; Gao Y; Bian HY; Zhao X
    J Inflamm Res; 2021; 14():5687-5697. PubMed ID: 34754215
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Serum copper level in non-Hodgkin's lymphomas.
    Salvagno L; Pappagallo GL; Chiarion Sileni V; Segati R; Cartei G; Endrizzi L; Paccagnella A; Ongaro G; Bonvicini P; Fiorentino MV
    Tumori; 1982 Feb; 68(1):57-62. PubMed ID: 7071946
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Convoluted cell lymphoblastic lymphoma (author's transl)].
    Rilke F; Clemente C; Pilotti S; Musumeci R
    Tumori; 1975; 61(4):377-91. PubMed ID: 1224391
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Elevation of serum lactic dehydrogenase levels as an early marker of occult malignant lymphoma.
    Rotenberg Z; Weinberger I; Fuchs Y; Erdberg A; Davidson E; Agmon J
    Cancer; 1984 Oct; 54(7):1379-81. PubMed ID: 6467160
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Extranodal lymphoma with an unusual constellation of features.
    McDonald CR; Paine CJ
    South Med J; 1975 Sep; 68(9):1177-9. PubMed ID: 1162433
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Lactate dehydrogenase (LDH) in peripheral blood lymphocytes (PBL) of patients with solid tumors].
    Konjević G; Jurisić V; Jakovljević B; Spuzić I
    Glas Srp Akad Nauka Med; 2002; (47):137-47. PubMed ID: 16078448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.